VolitionRx Signs Non-Binding LOI With Missionpharma for NETosis Technology
VolitionRx says it executed a non-binding letter of intent with Missionpharma to explore development and worldwide launch of its lateral flow technology for NETosis.
VolitionRx says it executed a non-binding letter of intent with Missionpharma to explore development and worldwide launch of its lateral flow technology for NETosis.